$ABBV

Robert A. Michael

AbbVie

CEO • Since 2024 • Health Care

📊 CEO Reputation Score

FY2025 vs FY2024 · Source: SEC EDGAR filings

36/100

Blend of this company's year-over-year free-cash-flow and profit improvement, each ranked as a percentile against every scored company in the three indexes.

Free cash flow: $17.8B → $17.8B (−0.1% YoY) — fiscal 2025 vs fiscal 2024
Profit (net income): $4.3B → $4.2B (−1.2% YoY) — fiscal 2025 vs fiscal 2024

How this score works · S&P 500 reputation leaderboard

Overview

Robert A. Michael is the ceo of AbbVie since 2024. AbbVie is a Health Care company headquartered in North Chicago, Illinois, founded in 2013, and one of the 500 companies in the S&P 500 — every one of which is profiled on this site.

Leadership

Robert holds the chief executive role at AbbVie with the title CEO — in post since 2024. This page is the concise leadership record for AbbVie in the S&P 500 CEO index; the site's fully researched long-form profiles (career timelines, education, achievements, setbacks, philosophy and sourced quotes) currently cover the index's ten largest companies, and this entry will be expanded in the same format.

At a Glance

Sector: Health Care
Ticker: $ABBV
Headquarters: North Chicago, Illinois
Founded: 2013
CEO since: 2024
Index: S&P 500 (#4 of 500)